APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coronavirus Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Coronavirus Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025194 pages

Choose your research edition.

Industry ResearchCoronavirus Treatment Drugs Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Coronavirus Treatment Drugs Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Coronavirus Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coronavirus Treatment Drugs Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Coronavirus Treatment Drugs Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Coronavirus Treatment Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Coronavirus Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Coronavirus Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coronavirus Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Coronavirus Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Coronavirus Treatment Drugs include Bharat Biotech International Limited, Cadila Healthcare Limited, CanSino Biologics, Celltrion Healthcare, Dr. Reddy's Laboratories, Gilead Sciences, Glenmark Pharmaceuticals Limited, Moderna and Novavax, Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Coronavirus Treatment Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Coronavirus Treatment Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Coronavirus Treatment Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Coronavirus Treatment Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Coronavirus Treatment Drugs Segment by Company

Bharat Biotech International Limited

Cadila Healthcare Limited

CanSino Biologics

Celltrion Healthcare

Dr. Reddy's Laboratories

Gilead Sciences

Glenmark Pharmaceuticals Limited

Moderna

Novavax, Inc

Serum Institute of India

Sinovac Biotech

Sorrento Therapeutics

AstraZeneca Plc

GlaxoSmithKline Plc

Pfizer Inc

Eli Lilly and Company

Roche

Merck & Co., Inc

Johnson & Johnson

Coronavirus Treatment Drugs Segment by Type

Monoclonal Antibodies

Kinase Inhibitors

Anti-viral

Corticosteroids

Others

Coronavirus Treatment Drugs Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Coronavirus Treatment Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coronavirus Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coronavirus Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coronavirus Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Coronavirus Treatment Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Coronavirus Treatment Drugs industry.

Chapter 3: Detailed analysis of Coronavirus Treatment Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Coronavirus Treatment Drugsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Coronavirus Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Monoclonal Antibodies Table 3. Key Players of Kinase Inhibitors Table 4. Key Players of Anti-viral Table 3. Key Players of Corticosteroids Table 4. Key Players of Others Table 5. Global Coronavirus Treatment Drugs Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Retail Pharmacies Table 7. Key Players of Online Pharmacies Table 8. Key Players of Hospital Pharmacies Table 9. Global Coronavirus Treatment Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Coronavirus Treatment Drugs Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Coronavirus Treatment Drugs Market Share by Region (2021-2026) Table 12. Global Coronavirus Treatment Drugs Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Coronavirus Treatment Drugs Market Share by Region (2027-2032) Table 14. Coronavirus Treatment Drugs Industry Trends Table 15. Coronavirus Treatment Drugs Industry Drivers Table 16. Coronavirus Treatment Drugs Industry Opportunities and Challenges Table 17. Coronavirus Treatment Drugs Industry Restraints Table 18. Global Coronavirus Treatment Drugs Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Coronavirus Treatment Drugs Revenue Market Share by Company (2021-2026) Table 20. Global Coronavirus Treatment Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Coronavirus Treatment Drugs Key Company Head Office and Area Served Table 22. Global Coronavirus Treatment Drugs Company, Product Type & Application Table 23. Global Coronavirus Treatment Drugs Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Coronavirus Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Coronavirus Treatment Drugs Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Coronavirus Treatment Drugs Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Coronavirus Treatment Drugs Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Coronavirus Treatment Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Coronavirus Treatment Drugs Revenue Market Share by Type (2027-2032) Table 31. Global Coronavirus Treatment Drugs Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Coronavirus Treatment Drugs Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Coronavirus Treatment Drugs Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Coronavirus Treatment Drugs Revenue Market Share by Application (2021-2026) Table 35. Global Coronavirus Treatment Drugs Revenue Market Share by Application (2027-2032) Table 36. Bharat Biotech International Limited Company Information Table 37. Bharat Biotech International Limited Business Overview Table 38. Bharat Biotech International Limited Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Bharat Biotech International Limited Coronavirus Treatment Drugs Product Portfolio Table 40. Bharat Biotech International Limited Recent Development Table 41. Cadila Healthcare Limited Company Information Table 42. Cadila Healthcare Limited Business Overview Table 43. Cadila Healthcare Limited Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Cadila Healthcare Limited Coronavirus Treatment Drugs Product Portfolio Table 45. Cadila Healthcare Limited Recent Development Table 46. CanSino Biologics Company Information Table 47. CanSino Biologics Business Overview Table 48. CanSino Biologics Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. CanSino Biologics Coronavirus Treatment Drugs Product Portfolio Table 50. CanSino Biologics Recent Development Table 51. Celltrion Healthcare Company Information Table 52. Celltrion Healthcare Business Overview Table 53. Celltrion Healthcare Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Celltrion Healthcare Coronavirus Treatment Drugs Product Portfolio Table 55. Celltrion Healthcare Recent Development Table 56. Dr. Reddy's Laboratories Company Information Table 57. Dr. Reddy's Laboratories Business Overview Table 58. Dr. Reddy's Laboratories Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Dr. Reddy's Laboratories Coronavirus Treatment Drugs Product Portfolio Table 60. Dr. Reddy's Laboratories Recent Development Table 61. Gilead Sciences Company Information Table 62. Gilead Sciences Business Overview Table 63. Gilead Sciences Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Gilead Sciences Coronavirus Treatment Drugs Product Portfolio Table 65. Gilead Sciences Recent Development Table 66. Glenmark Pharmaceuticals Limited Company Information Table 67. Glenmark Pharmaceuticals Limited Business Overview Table 68. Glenmark Pharmaceuticals Limited Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Glenmark Pharmaceuticals Limited Coronavirus Treatment Drugs Product Portfolio Table 70. Glenmark Pharmaceuticals Limited Recent Development Table 71. Moderna Company Information Table 72. Moderna Business Overview Table 73. Moderna Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Moderna Coronavirus Treatment Drugs Product Portfolio Table 75. Moderna Recent Development Table 76. Novavax, Inc Company Information Table 77. Novavax, Inc Business Overview Table 78. Novavax, Inc Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Novavax, Inc Coronavirus Treatment Drugs Product Portfolio Table 80. Novavax, Inc Recent Development Table 81. Serum Institute of India Company Information Table 82. Serum Institute of India Business Overview Table 83. Serum Institute of India Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Serum Institute of India Coronavirus Treatment Drugs Product Portfolio Table 85. Serum Institute of India Recent Development Table 86. Sinovac Biotech Company Information Table 87. Sinovac Biotech Business Overview Table 88. Sinovac Biotech Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Sinovac Biotech Coronavirus Treatment Drugs Product Portfolio Table 90. Sinovac Biotech Recent Development Table 91. Sorrento Therapeutics Company Information Table 92. Sorrento Therapeutics Business Overview Table 93. Sorrento Therapeutics Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Sorrento Therapeutics Coronavirus Treatment Drugs Product Portfolio Table 95. Sorrento Therapeutics Recent Development Table 96. AstraZeneca Plc Company Information Table 97. AstraZeneca Plc Business Overview Table 98. AstraZeneca Plc Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. AstraZeneca Plc Coronavirus Treatment Drugs Product Portfolio Table 100. AstraZeneca Plc Recent Development Table 101. GlaxoSmithKline Plc Company Information Table 102. GlaxoSmithKline Plc Business Overview Table 103. GlaxoSmithKline Plc Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. GlaxoSmithKline Plc Coronavirus Treatment Drugs Product Portfolio Table 105. GlaxoSmithKline Plc Recent Development Table 106. Pfizer Inc Company Information Table 107. Pfizer Inc Business Overview Table 108. Pfizer Inc Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Pfizer Inc Coronavirus Treatment Drugs Product Portfolio Table 110. Pfizer Inc Recent Development Table 111. Eli Lilly and Company Company Information Table 112. Eli Lilly and Company Business Overview Table 113. Eli Lilly and Company Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Eli Lilly and Company Coronavirus Treatment Drugs Product Portfolio Table 115. Eli Lilly and Company Recent Development Table 116. Roche Company Information Table 117. Roche Business Overview Table 118. Roche Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. Roche Coronavirus Treatment Drugs Product Portfolio Table 120. Roche Recent Development Table 121. Merck & Co., Inc Company Information Table 122. Merck & Co., Inc Business Overview Table 123. Merck & Co., Inc Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. Merck & Co., Inc Coronavirus Treatment Drugs Product Portfolio Table 125. Merck & Co., Inc Recent Development Table 126. Johnson & Johnson Company Information Table 127. Johnson & Johnson Business Overview Table 128. Johnson & Johnson Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 129. Johnson & Johnson Coronavirus Treatment Drugs Product Portfolio Table 130. Johnson & Johnson Recent Development Table 131. North America Coronavirus Treatment Drugs Market Size by Type (2021-2026) & (US$ Million) Table 132. North America Coronavirus Treatment Drugs Market Size by Type (2027-2032) & (US$ Million) Table 133. North America Coronavirus Treatment Drugs Market Size by Application (2021-2026) & (US$ Million) Table 134. North America Coronavirus Treatment Drugs Market Size by Application (2027-2032) & (US$ Million) Table 135. North America Coronavirus Treatment Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Coronavirus Treatment Drugs Market Size by Country (2021-2026) Table 137. North America Coronavirus Treatment Drugs Market Size by Country (2027-2032) Table 138. Europe Coronavirus Treatment Drugs Market Size by Type (2021-2026) & (US$ Million) Table 139. Europe Coronavirus Treatment Drugs Market Size by Type (2027-2032) & (US$ Million) Table 140. Europe Coronavirus Treatment Drugs Market Size by Application (2021-2026) & (US$ Million) Table 141. Europe Coronavirus Treatment Drugs Market Size by Application (2027-2032) & (US$ Million) Table 142. Europe Coronavirus Treatment Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe Coronavirus Treatment Drugs Market Size by Country (2021-2026) Table 144. Europe Coronavirus Treatment Drugs Market Size by Country (2027-2032) Table 145. China Coronavirus Treatment Drugs Market Size by Type (2021-2026) & (US$ Million) Table 146. China Coronavirus Treatment Drugs Market Size by Type (2027-2032) & (US$ Million) Table 147. China Coronavirus Treatment Drugs Market Size by Application (2021-2026) & (US$ Million) Table 148. China Coronavirus Treatment Drugs Market Size by Application (2027-2032) & (US$ Million) Table 149. Asia Coronavirus Treatment Drugs Market Size by Type (2021-2026) & (US$ Million) Table 150. Asia Coronavirus Treatment Drugs Market Size by Type (2027-2032) & (US$ Million) Table 151. Asia Coronavirus Treatment Drugs Market Size by Application (2021-2026) & (US$ Million) Table 152. Asia Coronavirus Treatment Drugs Market Size by Application (2027-2032) & (US$ Million) Table 153. Asia Coronavirus Treatment Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Asia Coronavirus Treatment Drugs Market Size by Country (2021-2026) Table 155. Asia Coronavirus Treatment Drugs Market Size by Country (2027-2032) Table 156. South America, Middle East & Africa Coronavirus Treatment Drugs Market Size by Type (2021-2026) & (US$ Million) Table 157. South America, Middle East & Africa Coronavirus Treatment Drugs Market Size by Type (2027-2032) & (US$ Million) Table 158. South America, Middle East & Africa Coronavirus Treatment Drugs Market Size by Application (2021-2026) & (US$ Million) Table 159. South America, Middle East & Africa Coronavirus Treatment Drugs Market Size by Application (2027-2032) & (US$ Million) Table 160. South America, Middle East & Africa Coronavirus Treatment Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. South America, Middle East & Africa Coronavirus Treatment Drugs Market Size by Country (2021-2026) Table 162. South America, Middle East & Africa Coronavirus Treatment Drugs Market Size by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Coronavirus Treatment Drugs Product Image Figure 2. Global Coronavirus Treatment Drugs Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Coronavirus Treatment Drugs Market Share by Type: 2025 VS 2032 Figure 4. Monoclonal Antibodies Image Figure 5. Kinase Inhibitors Image Figure 6. Anti-viral Image Figure 7. Corticosteroids Image Figure 8. Others Image Figure 9. Global Coronavirus Treatment Drugs Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Coronavirus Treatment Drugs Market Share by Application: 2025 VS 2032 Figure 11. Retail Pharmacies Image Figure 12. Online Pharmacies Image Figure 13. Hospital Pharmacies Image Figure 14. Global Coronavirus Treatment Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 16. Global Coronavirus Treatment Drugs Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Coronavirus Treatment Drugs Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Coronavirus Treatment Drugs Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Coronavirus Treatment Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Coronavirus Treatment Drugs Revenue Market Share by Type (2021-2032) Figure 23. Global Coronavirus Treatment Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Coronavirus Treatment Drugs Revenue Market Share by Application (2021-2032) Figure 25. North America Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 26. North America Coronavirus Treatment Drugs Market Share by Type (2021-2032) Figure 27. North America Coronavirus Treatment Drugs Market Share by Application (2021-2032) Figure 28. North America Coronavirus Treatment Drugs Market Share by Country (2021-2032) Figure 29. United States Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 30. Canada Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 32. Europe Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 33. Europe Coronavirus Treatment Drugs Market Share by Type (2021-2032) Figure 34. Europe Coronavirus Treatment Drugs Market Share by Application (2021-2032) Figure 35. Europe Coronavirus Treatment Drugs Market Share by Country (2021-2032) Figure 36. Germany Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 37. France Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 39. Italy Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 40. Russia Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 42. China Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 43. China Coronavirus Treatment Drugs Market Share by Type (2021-2032) Figure 44. China Coronavirus Treatment Drugs Market Share by Application (2021-2032) Figure 45. Asia Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 46. Asia Coronavirus Treatment Drugs Market Share by Type (2021-2032) Figure 47. Asia Coronavirus Treatment Drugs Market Share by Application (2021-2032) Figure 48. Asia Coronavirus Treatment Drugs Market Share by Country (2021-2032) Figure 49. Japan Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 53. India Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 54. Australia Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Coronavirus Treatment Drugs Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Coronavirus Treatment Drugs Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Coronavirus Treatment Drugs Market Share by Country (2021-2032) Figure 59. Brazil Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 64. UAE Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 66. Chile Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibodies
  • Kinase Inhibitors
  • Anti-viral
  • Corticosteroids
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Bharat Biotech International Limited
  • Cadila Healthcare Limited
  • CanSino Biologics
  • Celltrion Healthcare
  • Dr. Reddy's Laboratories
  • Gilead Sciences
  • Glenmark Pharmaceuticals Limited
  • Moderna
  • Novavax, Inc
  • Serum Institute of India
  • Sinovac Biotech
  • Sorrento Therapeutics
  • AstraZeneca Plc
  • GlaxoSmithKline Plc
  • Pfizer Inc
  • Eli Lilly and Company
  • Roche
  • Merck & Co., Inc
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Coronavirus Treatment Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Monoclonal Antibodies
  5. 1.2.3 Kinase Inhibitors
  6. 1.2.4 Anti-viral
  7. 1.2.5 Corticosteroids
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Coronavirus Treatment Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Retail Pharmacies
  12. 1.3.3 Online Pharmacies
  13. 1.3.4 Hospital Pharmacies
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Coronavirus Treatment Drugs Growth Trends by Region
  16. 1.5.1 Global Coronavirus Treatment Drugs Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Coronavirus Treatment Drugs Market Size by Region (2021-2026)
  18. 1.5.3 Coronavirus Treatment Drugs Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Coronavirus Treatment Drugs Market Dynamics
  1. 2.1 Coronavirus Treatment Drugs Industry Trends
  2. 2.2 Coronavirus Treatment Drugs Industry Drivers
  3. 2.3 Coronavirus Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Coronavirus Treatment Drugs Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Coronavirus Treatment Drugs Revenue by Company (2021-2026)
  2. 3.2 Global Coronavirus Treatment Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Coronavirus Treatment Drugs Key Company Head office and Area Served
  4. 3.4 Global Coronavirus Treatment Drugs Company, Product Type & Application
  5. 3.5 Global Coronavirus Treatment Drugs Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Coronavirus Treatment Drugs Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Coronavirus Treatment Drugs Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Coronavirus Treatment Drugs Tier 1, Tier 2, and Tier 3
4 Coronavirus Treatment Drugs Market by Type
  1. 4.1 Global Coronavirus Treatment Drugs Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Coronavirus Treatment Drugs Market Size by Type (2021-2032)
  3. 4.3 Global Coronavirus Treatment Drugs Market Size Share by Type (2021-2032)
5 Coronavirus Treatment Drugs Market by Application
  1. 5.1 Global Coronavirus Treatment Drugs Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Coronavirus Treatment Drugs Market Size by Application (2021-2032)
  3. 5.3 Global Coronavirus Treatment Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Bharat Biotech International Limited
  2. 6.1.1 Bharat Biotech International Limited Company Information
  3. 6.1.2 Bharat Biotech International Limited Business Overview
  4. 6.1.3 Bharat Biotech International Limited Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Bharat Biotech International Limited Coronavirus Treatment Drugs Product Portfolio
  6. 6.1.5 Bharat Biotech International Limited Recent Developments
  7. 6.2 Cadila Healthcare Limited
  8. 6.2.1 Cadila Healthcare Limited Company Information
  9. 6.2.2 Cadila Healthcare Limited Business Overview
  10. 6.2.3 Cadila Healthcare Limited Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Cadila Healthcare Limited Coronavirus Treatment Drugs Product Portfolio
  12. 6.2.5 Cadila Healthcare Limited Recent Developments
  13. 6.3 CanSino Biologics
  14. 6.3.1 CanSino Biologics Company Information
  15. 6.3.2 CanSino Biologics Business Overview
  16. 6.3.3 CanSino Biologics Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 CanSino Biologics Coronavirus Treatment Drugs Product Portfolio
  18. 6.3.5 CanSino Biologics Recent Developments
  19. 6.4 Celltrion Healthcare
  20. 6.4.1 Celltrion Healthcare Company Information
  21. 6.4.2 Celltrion Healthcare Business Overview
  22. 6.4.3 Celltrion Healthcare Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Celltrion Healthcare Coronavirus Treatment Drugs Product Portfolio
  24. 6.4.5 Celltrion Healthcare Recent Developments
  25. 6.5 Dr. Reddy's Laboratories
  26. 6.5.1 Dr. Reddy's Laboratories Company Information
  27. 6.5.2 Dr. Reddy's Laboratories Business Overview
  28. 6.5.3 Dr. Reddy's Laboratories Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Dr. Reddy's Laboratories Coronavirus Treatment Drugs Product Portfolio
  30. 6.5.5 Dr. Reddy's Laboratories Recent Developments
  31. 6.6 Gilead Sciences
  32. 6.6.1 Gilead Sciences Company Information
  33. 6.6.2 Gilead Sciences Business Overview
  34. 6.6.3 Gilead Sciences Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Gilead Sciences Coronavirus Treatment Drugs Product Portfolio
  36. 6.6.5 Gilead Sciences Recent Developments
  37. 6.7 Glenmark Pharmaceuticals Limited
  38. 6.7.1 Glenmark Pharmaceuticals Limited Company Information
  39. 6.7.2 Glenmark Pharmaceuticals Limited Business Overview
  40. 6.7.3 Glenmark Pharmaceuticals Limited Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Glenmark Pharmaceuticals Limited Coronavirus Treatment Drugs Product Portfolio
  42. 6.7.5 Glenmark Pharmaceuticals Limited Recent Developments
  43. 6.8 Moderna
  44. 6.8.1 Moderna Company Information
  45. 6.8.2 Moderna Business Overview
  46. 6.8.3 Moderna Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Moderna Coronavirus Treatment Drugs Product Portfolio
  48. 6.8.5 Moderna Recent Developments
  49. 6.9 Novavax, Inc
  50. 6.9.1 Novavax, Inc Company Information
  51. 6.9.2 Novavax, Inc Business Overview
  52. 6.9.3 Novavax, Inc Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Novavax, Inc Coronavirus Treatment Drugs Product Portfolio
  54. 6.9.5 Novavax, Inc Recent Developments
  55. 6.10 Serum Institute of India
  56. 6.10.1 Serum Institute of India Company Information
  57. 6.10.2 Serum Institute of India Business Overview
  58. 6.10.3 Serum Institute of India Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Serum Institute of India Coronavirus Treatment Drugs Product Portfolio
  60. 6.10.5 Serum Institute of India Recent Developments
  61. 6.11 Sinovac Biotech
  62. 6.11.1 Sinovac Biotech Company Information
  63. 6.11.2 Sinovac Biotech Business Overview
  64. 6.11.3 Sinovac Biotech Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Sinovac Biotech Coronavirus Treatment Drugs Product Portfolio
  66. 6.11.5 Sinovac Biotech Recent Developments
  67. 6.12 Sorrento Therapeutics
  68. 6.12.1 Sorrento Therapeutics Company Information
  69. 6.12.2 Sorrento Therapeutics Business Overview
  70. 6.12.3 Sorrento Therapeutics Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Sorrento Therapeutics Coronavirus Treatment Drugs Product Portfolio
  72. 6.12.5 Sorrento Therapeutics Recent Developments
  73. 6.13 AstraZeneca Plc
  74. 6.13.1 AstraZeneca Plc Company Information
  75. 6.13.2 AstraZeneca Plc Business Overview
  76. 6.13.3 AstraZeneca Plc Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 AstraZeneca Plc Coronavirus Treatment Drugs Product Portfolio
  78. 6.13.5 AstraZeneca Plc Recent Developments
  79. 6.14 GlaxoSmithKline Plc
  80. 6.14.1 GlaxoSmithKline Plc Company Information
  81. 6.14.2 GlaxoSmithKline Plc Business Overview
  82. 6.14.3 GlaxoSmithKline Plc Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 GlaxoSmithKline Plc Coronavirus Treatment Drugs Product Portfolio
  84. 6.14.5 GlaxoSmithKline Plc Recent Developments
  85. 6.15 Pfizer Inc
  86. 6.15.1 Pfizer Inc Company Information
  87. 6.15.2 Pfizer Inc Business Overview
  88. 6.15.3 Pfizer Inc Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Pfizer Inc Coronavirus Treatment Drugs Product Portfolio
  90. 6.15.5 Pfizer Inc Recent Developments
  91. 6.16 Eli Lilly and Company
  92. 6.16.1 Eli Lilly and Company Company Information
  93. 6.16.2 Eli Lilly and Company Business Overview
  94. 6.16.3 Eli Lilly and Company Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Eli Lilly and Company Coronavirus Treatment Drugs Product Portfolio
  96. 6.16.5 Eli Lilly and Company Recent Developments
  97. 6.17 Roche
  98. 6.17.1 Roche Company Information
  99. 6.17.2 Roche Business Overview
  100. 6.17.3 Roche Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Roche Coronavirus Treatment Drugs Product Portfolio
  102. 6.17.5 Roche Recent Developments
  103. 6.18 Merck & Co., Inc
  104. 6.18.1 Merck & Co., Inc Company Information
  105. 6.18.2 Merck & Co., Inc Business Overview
  106. 6.18.3 Merck & Co., Inc Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Merck & Co., Inc Coronavirus Treatment Drugs Product Portfolio
  108. 6.18.5 Merck & Co., Inc Recent Developments
  109. 6.19 Johnson & Johnson
  110. 6.19.1 Johnson & Johnson Company Information
  111. 6.19.2 Johnson & Johnson Business Overview
  112. 6.19.3 Johnson & Johnson Coronavirus Treatment Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Johnson & Johnson Coronavirus Treatment Drugs Product Portfolio
  114. 6.19.5 Johnson & Johnson Recent Developments
7 North America
  1. 7.1 North America Coronavirus Treatment Drugs Market Size (2021-2032)
  2. 7.2 North America Coronavirus Treatment Drugs Market Size by Type
  3. 7.2.1 North America Coronavirus Treatment Drugs Market Size by Type (2021-2026)
  4. 7.2.2 North America Coronavirus Treatment Drugs Market Size by Type (2027-2032)
  5. 7.2.3 North America Coronavirus Treatment Drugs Market Share by Type (2021-2032)
  6. 7.3 North America Coronavirus Treatment Drugs Market Size by Application
  7. 7.3.1 North America Coronavirus Treatment Drugs Market Size by Application (2021-2026)
  8. 7.3.2 North America Coronavirus Treatment Drugs Market Size by Application (2027-2032)
  9. 7.3.3 North America Coronavirus Treatment Drugs Market Share by Application (2021-2032)
  10. 7.4 North America Coronavirus Treatment Drugs Market Size by Country
  11. 7.4.1 North America Coronavirus Treatment Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Coronavirus Treatment Drugs Market Size by Country (2021-2026)
  13. 7.4.3 North America Coronavirus Treatment Drugs Market Size by Country (2027-2032)
  14. 7.4.4 North America Coronavirus Treatment Drugs Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Coronavirus Treatment Drugs Market Size (2021-2032)
  2. 8.2 Europe Coronavirus Treatment Drugs Market Size by Type
  3. 8.2.1 Europe Coronavirus Treatment Drugs Market Size by Type (2021-2026)
  4. 8.2.2 Europe Coronavirus Treatment Drugs Market Size by Type (2027-2032)
  5. 8.2.3 Europe Coronavirus Treatment Drugs Market Share by Type (2021-2032)
  6. 8.3 Europe Coronavirus Treatment Drugs Market Size by Application
  7. 8.3.1 Europe Coronavirus Treatment Drugs Market Size by Application (2021-2026)
  8. 8.3.2 Europe Coronavirus Treatment Drugs Market Size by Application (2027-2032)
  9. 8.3.3 Europe Coronavirus Treatment Drugs Market Share by Application (2021-2032)
  10. 8.4 Europe Coronavirus Treatment Drugs Market Size by Country
  11. 8.4.1 Europe Coronavirus Treatment Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Coronavirus Treatment Drugs Market Size by Country (2021-2026)
  13. 8.4.3 Europe Coronavirus Treatment Drugs Market Size by Country (2027-2032)
  14. 8.4.4 Europe Coronavirus Treatment Drugs Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Coronavirus Treatment Drugs Market Size (2021-2032)
  2. 9.2 China Coronavirus Treatment Drugs Market Size by Type
  3. 9.2.1 China Coronavirus Treatment Drugs Market Size by Type (2021-2026)
  4. 9.2.2 China Coronavirus Treatment Drugs Market Size by Type (2027-2032)
  5. 9.2.3 China Coronavirus Treatment Drugs Market Share by Type (2021-2032)
  6. 9.3 China Coronavirus Treatment Drugs Market Size by Application
  7. 9.3.1 China Coronavirus Treatment Drugs Market Size by Application (2021-2026)
  8. 9.3.2 China Coronavirus Treatment Drugs Market Size by Application (2027-2032)
  9. 9.3.3 China Coronavirus Treatment Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Coronavirus Treatment Drugs Market Size (2021-2032)
  2. 10.2 Asia Coronavirus Treatment Drugs Market Size by Type
  3. 10.2.1 Asia Coronavirus Treatment Drugs Market Size by Type (2021-2026)
  4. 10.2.2 Asia Coronavirus Treatment Drugs Market Size by Type (2027-2032)
  5. 10.2.3 Asia Coronavirus Treatment Drugs Market Share by Type (2021-2032)
  6. 10.3 Asia Coronavirus Treatment Drugs Market Size by Application
  7. 10.3.1 Asia Coronavirus Treatment Drugs Market Size by Application (2021-2026)
  8. 10.3.2 Asia Coronavirus Treatment Drugs Market Size by Application (2027-2032)
  9. 10.3.3 Asia Coronavirus Treatment Drugs Market Share by Application (2021-2032)
  10. 10.4 Asia Coronavirus Treatment Drugs Market Size by Country
  11. 10.4.1 Asia Coronavirus Treatment Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Coronavirus Treatment Drugs Market Size by Country (2021-2026)
  13. 10.4.3 Asia Coronavirus Treatment Drugs Market Size by Country (2027-2032)
  14. 10.4.4 Asia Coronavirus Treatment Drugs Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Coronavirus Treatment Drugs Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Coronavirus Treatment Drugs Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Coronavirus Treatment Drugs Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Coronavirus Treatment Drugs Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Coronavirus Treatment Drugs Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Coronavirus Treatment Drugs Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Coronavirus Treatment Drugs Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Coronavirus Treatment Drugs Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Coronavirus Treatment Drugs Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Coronavirus Treatment Drugs Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Coronavirus Treatment Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Coronavirus Treatment Drugs Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Coronavirus Treatment Drugs Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Coronavirus Treatment Drugs Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst